Raymond James & Associates’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ECAT
SCM
RCM
SIA
KIM
PCM
Raymond James & Associates's ECAT Position: Q3 2024 in Review
Raymond James & Associates increased its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 13% in Q3 2024, buying an estimated $129K and bringing the position to 63,034 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2623.
Raymond James & Associates first reported a position in ECAT in Q4 2022 and has held it in 8 quarters since. 65 funds tracked by Wall St. Rank hold ECAT as of Q3 2024.
- Raymond James & Associates held 63,034 shares of BlackRock ESG Capital Allocation Term Trust worth $1.12M as of Q3 2024.
- Raymond James & Associates bought 7,443 BlackRock ESG Capital Allocation Term Trust shares in Q3 2024, an estimated $129K.
- BlackRock ESG Capital Allocation Term Trust made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2623 holding.
- Raymond James & Associates first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2022 and has held it in 8 quarters since.
- 65 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.